BioCentury
ARTICLE | Company News

Eli Lilly, Regen BioPharma deal

July 18, 2016 7:00 AM UTC

Regen and Eli Lilly partnered to evaluate Lilly compounds with Regen’s nuclear receptor subfamily 2 group F member 6 ( NR2F6; COUP-TFIII) high throughput screening program. Regen will screen 21,000 ...